Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Crotoxin - Celtic Biotech Iowa

Next Previous
Drug Profile

Crotoxin - Celtic Biotech Iowa

Alternative Names: CB24; Cytotoxic PLA2; NSC-624244

Latest Information Update: 25 Sep 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ventech
  • Developer Celtic Biotech Iowa
  • Class Antineoplastics; Snake venoms
  • Mechanism of Action Apoptosis stimulants; Phospholipase A2 modulators; Protein kinase C stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Non-small cell lung cancer; Solid tumours
  • Discontinued Cancer

Most Recent Events

  • 25 Sep 2025 Crotoxin is still in phase I trials for Solid tumours in France (IV) (Celtic Biotech pipeline, September 2025)
  • 25 Sep 2025 Celtic Biotech plans a phase II trial for Solid tumours and Non-small cell lung cancer (Celtic Biotech pipeline, September 2025)
  • 24 Sep 2025 Phase-I clinical trials in Non-small cell lung cancer (IV) (Celtic Biotech Iowa pipeline, September 2025)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top